{
  "prompt": {
    "transcript": "**OBSTETRIC/GYNECOLOGICAL MEDICAL CLERKING – SBAR FORMAT**  \n\n---\n\n### **SITUATION:**  \n**Patient:** 28-year-old G2P1 (SVD 2019, no complications)  \n**Presenting Complaint:** Primary amenorrhea (never menstruated)  \n**Duration:** Lifelong  \n**Associated Symptoms:** No cyclical pelvic pain, no galactorrhea, normal secondary sexual characteristics (Tanner stage V breast/pubic hair). No hirsutism, acne, or virilization. No weight loss/gain, no heat/cold intolerance.  \n**Referred by:** GP for specialist evaluation  \n\n---\n\n### **BACKGROUND:**  \n**PMHx:** Nil significant. No chronic illnesses.  \n**Obstetric Hx:** G2P1 – 1x SVD at term (2019), no GDM/PE. Currently not pregnant (β-hCG negative).  \n**Gynecological Hx:** Never menstruated. No prior hormonal therapy. No dyspareunia.  \n**Surgical Hx:** Nil.  \n**FHx:** Mother had menarche at 14, no known Müllerian anomalies.  \n**Medications:** Nil regular. No OCP, no hormonal therapy.  \n**Allergies:** NKDA  \n**Social:** Non-smoker, occasional alcohol. Works as a teacher.  \n\n**Risk Factors:**  \n- Possible Müllerian agenesis (given absence of cyclical pain)  \n- Constitutional delay less likely (normal secondary sexual development)  \n- Consider PCOS (but no hyperandrogenism)  \n- Gonadal dysgenesis (e.g., Turner’s mosaic)  \n\n---\n\n### **ASSESSMENT:**  \n**Examination:**  \n- **Vitals:** BP 118/72 mmHg, HR 74 bpm, afebrile, BMI 22.4  \n- **General:** Well-appearing, no dysmorphic features.  \n- **Breasts:** Tanner V, no galactorrhea.  \n- **Abdomen:** Soft, non-tender, no masses.  \n- **Pelvic Exam (deferred pending imaging):** External genitalia normal. No vaginal dimple.  \n\n**Investigations:**  \n- **Bloods:**  \n  - FBC: Hb 13.2 g/dL, WBC 6.4 x10⁹/L, Plt 245 x10⁹/L  \n  - U&Es: Na 138 mmol/L, K 4.1 mmol/L, Cr 68 µmol/L  \n  - LFTs: Normal  \n  - Hormones:  \n    - FSH 4.2 IU/L, LH 3.8 IU/L (normal range)  \n    - Prolactin 210 mIU/L (normal)  \n    - TSH 1.8 mIU/L, fT4 14 pmol/L  \n    - Testosterone 1.4 nmol/L (normal female range)  \n  - Karyotype: Pending  \n- **Imaging:**  \n  - Pelvic USS: Absent uterus, small rudimentary uterine buds. Ovaries visualized, normal follicular count.  \n  - MRI Pelvis (if needed for Müllerian anomaly confirmation)  \n\n**Differential Diagnosis:**  \n1. **Müllerian agenesis (MRKH syndrome)** – Most likely given absent uterus on USS + normal secondary sexual characteristics.  \n2. **Complete androgen insensitivity syndrome (CAIS)** – Less likely (normal testosterone, but would expect absent pubic hair).  \n3. **Gonadal dysgenesis (e.g., Turner’s mosaic)** – Unlikely given normal FSH/LH, but karyotype needed.  \n4. **Hypothalamic/pituitary dysfunction** – Unlikely (normal FSH/LH, prolactin).  \n\n---\n\n### **RECOMMENDATION:**  \n1. **Confirm Diagnosis:**  \n   - **Karyotype** (rule out 46,XY DSD e.g., CAIS).  \n   - **MRI Pelvis** (if USS equivocal for Müllerian structures).  \n2. **Counseling:**  \n   - Discuss MRKH syndrome (if confirmed) – fertility implications (surrogacy required), vaginal dilation therapy vs. surgical neovagina if needed.  \n   - Psychosocial support (patient may need counseling re: fertility/body image).  \n3. **Endocrine Referral:**  \n   - If karyotype abnormal (e.g., Turner’s), assess for associated conditions (cardiac/aortic coarctation, thyroid dysfunction).  \n4. **Follow-Up:**  \n   - Review karyotype + MRI results in 2/52.  \n   - Consider multidisciplinary team input (gynecology, endocrinology, psychology).  \n   - Bone health monitoring (if hypogonadism confirmed).  \n\n**Plan:**  \n- If MRKH confirmed: Offer vaginal dilation therapy (Frank technique) when sexually active.  \n- If CAIS: Gonadectomy (risk of malignancy in undescended testes).  \n- If Turner’s: Cardiac echo, osteoporosis prophylaxis.  \n\n**Next Steps:**  \n- Repeat β-hCG if any doubt re: pregnancy.  \n- DEXA scan if long-term hypoestrogenic state.  \n\n**Documented by:** [Your Name], [Your Position]  \n**Time:** 1430 hours  \n\n--- \n\n**Note:** This is a fictional case for educational purposes. Always verify clinical details in real practice.",
    "guidelinesCount": 266,
    "chunksProcessed": 34,
    "chunksFailed": 0
  },
  "response": "{\n  \"success\": true,\n  \"categoriesFound\": 266,\n  \"mostRelevantCount\": 1,\n  \"potentiallyRelevantCount\": 10,\n  \"lessRelevantCount\": 46,\n  \"notRelevantCount\": 209\n}",
  "endpoint": "findRelevantGuidelines",
  "timestamp": "2025-06-27T12-48-54",
  "textContent": "AI: DeepSeek (deepseek-chat)\n\nQ: {\n  \"transcript\": \"**OBSTETRIC/GYNECOLOGICAL MEDICAL CLERKING – SBAR FORMAT**  \\n\\n---\\n\\n### **SITUATION:**  \\n**Patient:** 28-year-old G2P1 (SVD 2019, no complications)  \\n**Presenting Complaint:** Primary amenorrhea (never menstruated)  \\n**Duration:** Lifelong  \\n**Associated Symptoms:** No cyclical pelvic pain, no galactorrhea, normal secondary sexual characteristics (Tanner stage V breast/pubic hair). No hirsutism, acne, or virilization. No weight loss/gain, no heat/cold intolerance.  \\n**Referred by:** GP for specialist evaluation  \\n\\n---\\n\\n### **BACKGROUND:**  \\n**PMHx:** Nil significant. No chronic illnesses.  \\n**Obstetric Hx:** G2P1 – 1x SVD at term (2019), no GDM/PE. Currently not pregnant (β-hCG negative).  \\n**Gynecological Hx:** Never menstruated. No prior hormonal therapy. No dyspareunia.  \\n**Surgical Hx:** Nil.  \\n**FHx:** Mother had menarche at 14, no known Müllerian anomalies.  \\n**Medications:** Nil regular. No OCP, no hormonal therapy.  \\n**Allergies:** NKDA  \\n**Social:** Non-smoker, occasional alcohol. Works as a teacher.  \\n\\n**Risk Factors:**  \\n- Possible Müllerian agenesis (given absence of cyclical pain)  \\n- Constitutional delay less likely (normal secondary sexual development)  \\n- Consider PCOS (but no hyperandrogenism)  \\n- Gonadal dysgenesis (e.g., Turner’s mosaic)  \\n\\n---\\n\\n### **ASSESSMENT:**  \\n**Examination:**  \\n- **Vitals:** BP 118/72 mmHg, HR 74 bpm, afebrile, BMI 22.4  \\n- **General:** Well-appearing, no dysmorphic features.  \\n- **Breasts:** Tanner V, no galactorrhea.  \\n- **Abdomen:** Soft, non-tender, no masses.  \\n- **Pelvic Exam (deferred pending imaging):** External genitalia normal. No vaginal dimple.  \\n\\n**Investigations:**  \\n- **Bloods:**  \\n  - FBC: Hb 13.2 g/dL, WBC 6.4 x10⁹/L, Plt 245 x10⁹/L  \\n  - U&Es: Na 138 mmol/L, K 4.1 mmol/L, Cr 68 µmol/L  \\n  - LFTs: Normal  \\n  - Hormones:  \\n    - FSH 4.2 IU/L, LH 3.8 IU/L (normal range)  \\n    - Prolactin 210 mIU/L (normal)  \\n    - TSH 1.8 mIU/L, fT4 14 pmol/L  \\n    - Testosterone 1.4 nmol/L (normal female range)  \\n  - Karyotype: Pending  \\n- **Imaging:**  \\n  - Pelvic USS: Absent uterus, small rudimentary uterine buds. Ovaries visualized, normal follicular count.  \\n  - MRI Pelvis (if needed for Müllerian anomaly confirmation)  \\n\\n**Differential Diagnosis:**  \\n1. **Müllerian agenesis (MRKH syndrome)** – Most likely given absent uterus on USS + normal secondary sexual characteristics.  \\n2. **Complete androgen insensitivity syndrome (CAIS)** – Less likely (normal testosterone, but would expect absent pubic hair).  \\n3. **Gonadal dysgenesis (e.g., Turner’s mosaic)** – Unlikely given normal FSH/LH, but karyotype needed.  \\n4. **Hypothalamic/pituitary dysfunction** – Unlikely (normal FSH/LH, prolactin).  \\n\\n---\\n\\n### **RECOMMENDATION:**  \\n1. **Confirm Diagnosis:**  \\n   - **Karyotype** (rule out 46,XY DSD e.g., CAIS).  \\n   - **MRI Pelvis** (if USS equivocal for Müllerian structures).  \\n2. **Counseling:**  \\n   - Discuss MRKH syndrome (if confirmed) – fertility implications (surrogacy required), vaginal dilation therapy vs. surgical neovagina if needed.  \\n   - Psychosocial support (patient may need counseling re: fertility/body image).  \\n3. **Endocrine Referral:**  \\n   - If karyotype abnormal (e.g., Turner’s), assess for associated conditions (cardiac/aortic coarctation, thyroid dysfunction).  \\n4. **Follow-Up:**  \\n   - Review karyotype + MRI results in 2/52.  \\n   - Consider multidisciplinary team input (gynecology, endocrinology, psychology).  \\n   - Bone health monitoring (if hypogonadism confirmed).  \\n\\n**Plan:**  \\n- If MRKH confirmed: Offer vaginal dilation therapy (Frank technique) when sexually active.  \\n- If CAIS: Gonadectomy (risk of malignancy in undescended testes).  \\n- If Turner’s: Cardiac echo, osteoporosis prophylaxis.  \\n\\n**Next Steps:**  \\n- Repeat β-hCG if any doubt re: pregnancy.  \\n- DEXA scan if long-term hypoestrogenic state.  \\n\\n**Documented by:** [Your Name], [Your Position]  \\n**Time:** 1430 hours  \\n\\n--- \\n\\n**Note:** This is a fictional case for educational purposes. Always verify clinical details in real practice.\",\n  \"guidelinesCount\": 266,\n  \"chunksProcessed\": 34,\n  \"chunksFailed\": 0\n}\n\nA: {\n  \"success\": true,\n  \"categoriesFound\": 266,\n  \"mostRelevantCount\": 1,\n  \"potentiallyRelevantCount\": 10,\n  \"lessRelevantCount\": 46,\n  \"notRelevantCount\": 209\n}",
  "ai_provider": "DeepSeek",
  "ai_model": "deepseek-chat",
  "token_usage": null
}